Clinical Trial Update: A Registry-Based Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dysfunction Due to ALS [Phase 2]

View source ↗

Summary

Phase 2 registry-based clinical trial evaluating pimozide for neuromuscular junction transmission dysfunction in amyotrophic lateral sclerosis. Current study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Pimozide (Pimozide)

Snippet

Sponsor: University of Calgary | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: UNKNOWN